1. Home
  2. Affiliated Clinical Faculty
  1. Home
  2. Affiliated Clinical Faculty

The affiliated clinical faculty provide crucial clinical input into our strategy and research programmes, ensuring that everything we do has the potential to help cancer patients.  

We aim to create a truly collaborative environment, with dedicated space for our affiliated faculty within the Institute to host trainees and use our state-of-the-art facilities for clinical research.

Affiliated Clinical Faculty

  • Alt

    Prof Jean Abraham

    Professor of Precision Breast Cancer Medicine and an Honorary Consultant in Medical Oncology at the University of Cambridge. She directs the Precision Breast Cancer Institute and co-leads the Integrated Cancer Medicine theme and the Breast Programme in the Cancer Research UK Cambridge Centre.

  • Alt

    Prof Charlotte Coles

    Professor of Breast Cancer Clinical Oncology, University of Cambridge; NIHR Research Professor, and Director of CRUK RadNet Cambridge. She leads practice-changing breast radiotherapy trials, has influenced international hypofractionation policy and is addressing global health, gender, and equity challenges within the Lancet Breast Cancer Commission.

  • Alt

    Dr Kate Fife

    Consultant clinical oncologist at Cambridge University Hospitals NHSFT and afiliated assistant Professor, University of Cambridge. Her specialisms are kidney and skin cancers and she is principal investigator for national and international clinical trials, appointed to several trial management and trial development groups.

  • Alt

    Prof Rebecca Fitzgerald

    Professor of Cancer Prevention and Director of the Early Detection Institute at the University of Cambridge and practices medicine as Hon. Consultant in Gastroenterology and Cancer Medicine at Addenbrooke’s Hospital. Rebecca also leads the Cambridge component of the CRUK International Alliance in Early Detection (ACED). The focus of her research is to investigate the steps in malignant transformation in the oesophagus and stomach and to use this information to improve clinical early detection strategies.

  • Alt

    Prof Hugo Ford

    Assistant Professor of Neurosurgical Oncology at the University of Cambridge and Honorary Consultant Neurosurgeon at Addenbrooke’s Hospital, Cambridge. He is Co-Director of the CRUK Minderoo Brain Cancer Virtual Institute, Lead for the Minderoo Precision Brain Tumour Programme and Director of the ICARUS tissue bank and Glioma Liquid Biopsy Programme.

  • Alt

    Prof Serena Nik-Zainal

    Professor of Genomic Medicine and Bioinformatics and an Honorary NHS Consultant in Clinical Genetics in Cambridge. She is the lead of the Genomic Medicine theme at the NIHR Cambridge Biomedical Research Campus. Her team continues to spearhead the whole cancer genomics field through a combination of computational and experimental approaches, to ultimately create clinical applications.

  • Alt

    Prof Robert Rintoul

    Professor of Thoracic Oncology in the Department of Oncology, University of Cambridge and Honorary Consultant Respiratory Physician, Royal Papworth Hospital, Cambridge.   He is lead clinician for cancer at Royal Papworth Hospital and Director of the Papworth Trials Unit Collaboration.  He is co-lead for the CRUK Cambridge Centre Thoracic Cancer Programme, co-ordinating thoracic oncology research across Cambridge. In 2021 he was appointed Chair of the Clinical Advisory Group for the UK Lung Cancer Coalition.

  • Alt

    Prof Grant Stewart

    Professor of Surgical Oncology, University of Cambridge. He has a focus on developing and promoting surgery related clinical trials and translational research. As a urological surgeon, Grant has a specific interest in optimising management of patients with initially localised renal cancer. Grant co-leads the Urological Malignancy and Integrated Cancer Medicine Programmes. He is Director of the Academic Clinical Fellow Programme in Cambridge, Clinical Director of the National Kidney Cancer Audit and Clinical lead for the NICE Kidney Cancer Guideline.

Leadership

Our Directors, Executive Committee, and Scientific Advisory Board collaborate to define and execute our strategic vision.

Find out more